₹1325.30
+30.40
(+2.35%)
as on
as on September 8, 2025 at 4:01 pm IST
Day's Low
Day's High
7.18%
Downside
1.11%
Upside
52 Week's Low
52 Week's High
52.09%
Downside
1.11%
Upside
as on September 8, 2025 at 4:01 pm IST
Market Cap
₹611.41 Cr
Return on Equity (ROE)
14.34
PE Ratio (TTM)
0Return on capital employed (ROCE)
16.95
Beta (LTM)
0.4
P/B Ratio
2.81
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
63.92
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bullish
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Fredun Pharmaceuticals Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 611.41 | 94.72% | 0.00 | 15 | 348 | |
NA | 69.88 | 3.03% | 0.00 | 1 | 33 | |
NA | 44.49 | -17.01% | 0.00 | -22 | 104 | |
NA | 120.66 | 59.56% | 0.00 | 14 | 95 | |
NA | 162.34 | 98.3% | 0.00 | 6 | 113 |
Search interest for Fredun Pharmaceuticals Ltd Stock has decreased by -23% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
Numbers in percentages
View detailed summary of the earnings and dividend history of Fredun Pharmaceuticals Ltd.
Fredun Pharmaceuticals Ltd’s net profit jumped 63.92% since last year same period to ₹6.77Cr in the Q1 2025-2026. On a quarterly growth basis, Fredun Pharmaceuticals Ltd has generated 12.83% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Fredun Pharmaceuticals Ltd has declared dividend of ₹0.70 per share on 07 May 2024 - translating a dividend yield of 0.11%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 7 days, Fredun Pharma stock has moved up by 10.1%
Best in 1 Year
In the last 1 year, Fredun Pharma has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.1% return, outperforming this stock by 117.0%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 48.93% of holdings in Jun 2025 quarter
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 49.48% of holdings in Jun 2025 quarter
Organisation | Fredun Pharmaceuticals Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
CEO | Daulat N Medhora |
E-voting on shares | Click here to vote |
Fredun Pharmaceuticals Ltd share price today stands at ₹1325.3 as on at the close of the market. Fredun Pharmaceuticals Ltd share today touched a day high of ₹1340 and a low of ₹1230.2.
Fredun Pharmaceuticals Ltd touched a 52 week high of ₹1340 and a 52 week low of ₹635. Fredun Pharmaceuticals Ltd share price today i.e. is closed at ₹1325.3, which is -1.10% down from its 52 week high and 108.71% up from its 52 week low.
Fredun Pharmaceuticals Ltd market capitalisation is ₹611.41 Cr as on .
To buy Fredun Pharmaceuticals Ltd shares, you need to follow these steps:
Fredun Pharmaceuticals Ltd trading volume is 35.52K as on . This means that 35.52K shares of Fredun Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.